Trade Mark Journal No.2025/024 13 June 2025
WO0000001857486 (44)
Office of origin: United States of America
Date of International Registration:19 March 2025
Date of designation in the UK:
19 March 2025
- Class 44
- Medical diagnostic services; medical testing services; medical analysis services; medical testing for diagnostic or treatment purposes; medical analysis for diagnostic or treatment purposes; medical and medical clinical diagnostic testing, monitoring and reporting services: in vitro testing for medical and pharmaceutical use; medical treatment using cultured cells; medical analysis services for cancer diagnosis and prognosis; providing medical and medical clinical data analytics and bioinformatics services; medical analysis services for the diagnosis of cancer and other diseases in human and animals; health care services, namely, providing medical information in the field of cancer and other human and animal diseases via a database, all for treatment and diagnostic purposes; providing medical and paramedical information via a website and online portal; providing information and advice in the field of pet health; health information services in the fields of medical, health, or clinical care; veterinary specialty services providing advanced medical, diagnostic or surgical services for animals.
ImpriMed, Inc.
Representative: Beatrice Martinet Sideman & Bancroft LLP, One Embarcadero Center, Suite 2200, San Francisco CA 94111, UNITED STATES OF AMERICA